Skip to main content
Log in

Cooperative Interactions at M2 Muscarinic Acetylcholine Receptors: Structure/Activity Relationships in Stepwise Shortened Bispyridinium- and Bis(Ammonio)Alkane-Type Allosteric Modulators

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Muscarinic M2-receptors allow for divergent modes of allosteric action, depending on the structure of the allosteric modulator. Phthalimido-substituted bis(ammonio)alkane-type modulators belong to the common mode allosteric agents, whereas a physicochemically closely related bispyridinium-oxime with dichlorobenzyl-substituents at both ends is an atypical agent. Here, we compared the actions of stepwise shortened compounds composed of the phthalimido moiety and middle chains of either the bispyridinium- or the bis(ammonio)alkane-type. Allosteric interactions were measured in pig M2 receptors with the orthosteric probe [3H]N-methylscopolamine ([3H]NMS) to label the acetylcholine binding site of the receptors. Dissociation and equilibrium binding experiments revealed parallel structure/activity-relationships in both series of compounds with regard to the cooperativity of interaction with [3H]NMS and to the underlying binding affinities in radioligand-occupied and free receptors. In conclusion, the findings are in line with the hypothesis that the phthalimido-moiety, but not the middle chain, is pivotal for the topology of interaction with the M2-receptor protein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Christopoulos, A. 2002. Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery. Nat. Rev. Drug Discov. 1:198–210.

    PubMed  Google Scholar 

  2. Tränkle, C., Andresen, I., Lambrecht, G., and Mohr, K. 1998. M2 receptor binding of the selective antagonist AF-DX 384: Possible involvement of the common allosteric site. Mol. Pharmacol. 53:304–312.

    PubMed  Google Scholar 

  3. Stockton, J. M., Birdsall, N. J. M., Burgen, A. S. V., and Hulme, E. C. 1983. Modification of the binding properties of the muscarinic receptors by gallamine. Mol. Pharmacol. 23:551–557.

    PubMed  Google Scholar 

  4. Ehlert, F. J. 1988. Estimation of the affinities of allosteric ligands using radioligand and pharmacological null methods. Mol. Pharmacol. 83:187–194.

    Google Scholar 

  5. Soudijn, W., van Wijngaarden, I., and IJzerman, A. P. 2001. Allosteric modulation of G-protein-coupled receptors. Expert Opin. Ther. Patents 11:1889–1904.

    Google Scholar 

  6. Christopoulos, A. and Kenakin, T. 2002. G-Protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54:323–374.

    PubMed  Google Scholar 

  7. Tuček, S. and Proška, J. 1995. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16:205–212.

    PubMed  Google Scholar 

  8. Ellis, J. 1997. Allosteric binding sites on muscarinic receptors. Drug Dev. Res. 40:193–204.

    Google Scholar 

  9. Holzgrabe, U. and Mohr, K. 1998. Allosteric modulators of ligand binding to muscarinic acetylcholine receptors. Drug Discovery Today 3:214–222.

    Google Scholar 

  10. Mohr, K., Tränkle, C., and Holzgrabe, U. Structure/activity-relationships of muscarinic allosteric modulators. Receptors and Channels (in the press).

  11. Jakubík, J., Bačáková, L., El-Fakahany, E. E., and Tučcek, S. 1997. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol. Pharmacol. 52:172–179.

    PubMed  Google Scholar 

  12. Dolezal, V. and Tučcek, S. 1998. The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptors agonists. Br. J. Pharmacol. 124:1213–1218.

    PubMed  Google Scholar 

  13. Birdsall, N. J. M., Farries, T., Gharagozloo, P., Kobayashi, S., Lazareno, S., and Sugimoto, M. 1999. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: Functional studies. Mol. Pharmacol. 55:778–786.

    PubMed  Google Scholar 

  14. Jakubík, J., Bačáková, L., Lisa, V., El-Fakahany, E. E., and Tučcek, S. 1996. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc. Natl. Acad. Sci. USA 93:8705–8709.

    PubMed  Google Scholar 

  15. Jakubík, J., Haga, T., and Tuček, S. 1998. Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-[35S] thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry. Mol. Pharmacol. 54:899–906.

    PubMed  Google Scholar 

  16. Zahn, K., Eckstein, N., Tränkle, C., Sadeé, W., and Mohr, K. 2002. Allosteric modulation of muscarinic receptor signaling: Alcuronium-induced conversion of pilocarpine from an agonist into an antagonist. J. Pharmacol. Exp. Ther. 301:720–728.

    PubMed  Google Scholar 

  17. Jakubík, J. and Tuček, S. 1995. Positive allosteric interactions on cardiac muscarinic receptors: Effects of chemical modification of disulphide and carboxyl groups. Eur. J. Pharmacol. 289:311–319.

    PubMed  Google Scholar 

  18. Ellis, J., Seidenberg, M., and Brann, M. R. 1993. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol. Pharmacol. 44:583–588.

    PubMed  Google Scholar 

  19. Leppik, R. A., Miller, R. C., Eck, M., and Paquet, J. L. 1994. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the M2 muscarinic acetylcholine receptor. Mol. Pharmacol. 45:983–990.

    PubMed  Google Scholar 

  20. Gnagey, A. L., Seidenberg, M., and Ellis, J. 1999. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors. Mol. Pharmacol. 56:1245–1253.

    PubMed  Google Scholar 

  21. Ellis, J. and Seidenberg, M. 2000. Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: Studies with chimeric receptors. Mol. Pharmacol. 58:1451–1460.

    PubMed  Google Scholar 

  22. Krejčí, A. and Tuček, S. 2001. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors. Mol. Pharmacol. 60:761–767.

    PubMed  Google Scholar 

  23. Buller, S., Zlotos, D. P., Mohr, K., and Ellis, J. 2002. Allosteric site on muscarinic acetylcholine receptors: A single amino acid in TM7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands. Mol. Pharmacol. 61:160–168.

    Google Scholar 

  24. Ellis, J. and Seidenberg, M. 1992. Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol. Pharmacol. 42:638–641.

    PubMed  Google Scholar 

  25. Bejeuhr, G., Holzgrabe, U., Mohr, K., Sürig, U., and v. Petersenn, A. 1992. Molecular modelling and synthesis of potent stabilizers of antagonist binding to M2-cholinoceptors. Pharm. Pharmacol. Lett. 2:100–103.

    Google Scholar 

  26. Tränkle, C. and Mohr, K. 1997. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors. Mol. Pharmacol. 51:674–682.

    PubMed  Google Scholar 

  27. Schröter, A., Tränkle, C., and Mohr, K. 2000. Modes of allosteric interactions with free and [3H]N-methylscopolamine occupied muscarinic M2 receptors as deduced from buffer dependent potency shifts. Naunyn Schmiedebergs Arch. Pharmacol. 362:512–519.

    PubMed  Google Scholar 

  28. Kostenis, E., Holzgrabe, U., and Mohr, K. 1994. Allosteric effect on muscarinic M2-receptors of derivatives of the alkane-bis-ammonium compound W84: Comparison with bispyridinium-type allosteric modulators. Eur. J. Med. Chem. 29:947–953.

    Google Scholar 

  29. Kostenis, E., Botero Cid, H. M., Holzgrabe, U., and Mohr, K. 1996. Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors. Eur. J. Pharmacol. 314:385–392.

    PubMed  Google Scholar 

  30. Botero Cid, H. M., Holzgrabe, U., Kostenis, E., Mohr, K., and Tränkle, C. 1994. Search for the phamacophore of bispyridinium-type allosteric modulators of muscarinic receptors. J. Med. Chem. 37:1439–1445.

    PubMed  Google Scholar 

  31. Tränkle, C., Kostenis, E., Burgmer, U., and Mohr, K. 1996. Search for lead structures to develop new allosteric modulators of muscarinic receptors. J. Pharmacol. Exp. Ther. 279:926–933.

    PubMed  Google Scholar 

  32. Krejčí, A. and Tuček, S. 2002. Quantitation of mRNAs for M(1) to M(5) subtypes of muscarinic receptors in rat heart and brain cortex. Mol. Pharmacol. 61:1267–1272.

    PubMed  Google Scholar 

  33. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275.

    PubMed  Google Scholar 

  34. Lazareno, S. and Birdsall, N. J. M. 1995. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48:362–378.

    PubMed  Google Scholar 

  35. Tränkle, C., Mies-Klomfaß, E., Botero Cid, M. H., Holzgrabe, U., and Mohr, K. 1998. Identification of a [3H]ligand for the common allosteric site of muscarinic acetylcholine M2 receptors. Mol. Pharmacol. 54:139–145.

    PubMed  Google Scholar 

  36. Christopoulos, A. 1998. Assessing the distribution of parameters in models of ligand-receptor interaction: To log or not to log. Trends Pharmacol. Sci. 19:351–357.

    PubMed  Google Scholar 

  37. Raasch, A., Scharfenstein, O., Tränkle, C., Holzgrabe, U., and Mohr, K. 2002. Elevation of ligand binding to muscarinic M2 acetylcholine receptors by bis(ammonio)alkane-type allosteric modulators. J. Med. Chem. 45:3809–3812.

    PubMed  Google Scholar 

  38. Lazareno, S., Popham, A., and Birdsall, N. J. M. 2000. Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: Identification of a second allosteric site. Mol. Pharmacol. 58:194–207.

    PubMed  Google Scholar 

  39. Kostenis, E. and Mohr, K. 1996. Composite action of allosteric modulators on ligand binding. Trends Pharmacol. Sci. 17:443–444.

    PubMed  Google Scholar 

  40. Lysíková, M., Havlas, Z., and Tuček, S. 2001. Interaction between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: Potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists. Neurochem. Res. 26:383–394.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gilsbach, R., Großmüller, M., Alptüzün, V. et al. Cooperative Interactions at M2 Muscarinic Acetylcholine Receptors: Structure/Activity Relationships in Stepwise Shortened Bispyridinium- and Bis(Ammonio)Alkane-Type Allosteric Modulators. Neurochem Res 28, 667–673 (2003). https://doi.org/10.1023/A:1022858414900

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022858414900

Navigation